Andriy Gudzenko: Difference between revisions
Expand source-linked author records; preserve work-specific attribution |
Add complete multilingual reference and language navigation |
||
| Line 1: | Line 1: | ||
<div class="wiki-language-nav" style="padding:0.75em; border:1px solid #b5c8cd; border-radius:0.5em; margin-bottom:1em;">[[Andriy Gudzenko|English]] · [[Andriy Gudzenko/uk|Українська]] · [[Andriy Gudzenko/es|Español]] · [[Andriy Gudzenko/fr|Français]] · [[Andriy Gudzenko/de|Deutsch]] · [[Andriy Gudzenko/pt|Português]]</div> | |||
'''Andriy Gudzenko''' is recorded as an author in the public publication source below. This is a publication-linked research record, not a complete biography. | '''Andriy Gudzenko''' is recorded as an author in the public publication source below. This is a publication-linked research record, not a complete biography. | ||
Latest revision as of 00:52, 12 November 2026
Andriy Gudzenko is recorded as an author in the public publication source below. This is a publication-linked research record, not a complete biography.
Documented work
The 2021 Science Review paper examines complaints about medicine provision for privileged patient categories.
Research context: Access to medicines and forensic-pharmaceutical analysis.
Named collaborators on this work: Valentyn Shapovalov, Valerii Shapovalov and Viktoriia Shapovalova.
Identity and evidence notes
Also transliterated Andrii Hudzenko. The 2016 servicemen study names Andrii Oleksandrovych Hudzenko. 2016 publisher record. Do not merge other Gudzenko authors solely by surname.
Inclusion records authorship of the cited work, not endorsement of every later Vision 2035 proposal. Publication affiliations are historical unless separately updated.
See People and attribution and Research network.